Scientists at Johns Hopkins University have identified a surprising process that helps humans develop sharp vision before birth, a finding that challenges long-standing assumptions about how the eye takes shape. Working with miniature human retinas grown in the laboratory, the researchers found that a vitamin A derivative and thyroid hormones act together to shape the foveola, the small region at the center of the retina that delivers our sharpest visual detail.
The foveola is central to everyday seeing. It is the part of the eye used for reading, recognizing faces and judging fine detail, and its structure must be correctly formed during development for those abilities to work well. Because the process unfolds before birth, it has been difficult to observe directly in people, which is one reason the use of lab-grown retinal tissue was central to the work.
The discovery is notable because it points to a coordinated role for two chemical signals that were not previously understood to be working in tandem on this structure. By showing how these factors interact during early eye formation, the team has altered existing thinking about the biological steps that produce the high-resolution center of the retina.
Researchers say the findings may help scientists better understand how normal retinal development occurs and what could go wrong when it does not. Clarifying these early steps is a necessary foundation for studying conditions that affect the central retina, although the source material does not detail specific diseases or treatments that the work will address.
The study adds to a growing body of research using miniature organ models, sometimes called organoids, to examine human tissue development in settings that would otherwise be inaccessible. Such models allow scientists to test how individual chemical signals influence growth without relying solely on animal studies or observations after birth.
14
